Invasive Ductal Carcinoma (IDC)

Contact

At Tucson Breast Health Specialists, we understand that a diagnosis of Invasive Ductal Carcinoma (IDC) can be overwhelming. Our compassionate team, led by Dr. Michele Ley, MD, FACS, is here to guide you through understanding IDC, the treatment options available, and the care plan that best fits your needs and lifestyle.

What is Invasive Ductal Carcinoma?

Invasive Ductal Carcinoma (IDC) is the most common type of breast cancer, accounting for approximately 70–80% of all breast cancer diagnoses. IDC begins in the milk ducts of the breast and then “invades” nearby breast tissue. This is different from ductal carcinoma in situ (DCIS), which remains confined to the ducts and is considered non-invasive.

Risk factors include a family history of breast cancer, certain genetic mutations, prior breast conditions, and lifestyle factors.

Diagnosing IDC

A diagnosis of IDC usually begins with routine screening mammography or a breast exam. If a suspicious area is identified, a biopsy is performed to confirm the presence of invasive cancer. Additional imaging, such as ultrasound or MRI, may be recommended to assess the extent of the disease.

Once confirmed, your care team will evaluate the tumor size, location, lymph node involvement, and hormone receptor status to guide personalized treatment planning. At Tucson Breast Health Specialists, we emphasize shared decision-making, ensuring patients understand their diagnosis and the treatment options available.

Treatment Approaches for IDC

Treatment for IDC is highly individualized, depending on the type and stage of cancer, as well as the patient’s overall health and personal preferences. Dr. Ley and our team focus on minimally invasive techniques and oncoplastic surgery to optimize outcomes while preserving breast appearance whenever possible.

Surgical Options

  • Lumpectomy or Partial mastectomy– Also called breast-conserving surgery, removes the cancerous tumor and a margin of surrounding tissue while preserving most of the breast. 
  • Mastectomy – Removes the entire breast, sometimes recommended for larger tumors or when multiple areas of the breast are affected.

Adjunct Therapies

  • Radiation Therapy – Usually recommended after a lumpectomy to reduce the risk of recurrence. 
  • Medical Therapy – This may include chemotherapy, hormone therapy, or targeted therapy, depending on the tumor’s characteristics. 

Our holistic approach ensures that treatment is tailored to each patient’s needs, balancing the effectiveness of cancer control with quality-of-life considerations.

Why Choose Tucson Breast Health Specialists?

Dr. Ley is not only an experienced breast surgical oncologist but also a breast cancer survivor, giving her a personal perspective on the challenges patients face. She and our providers focus on:

  • Building meaningful patient connections
  • Understanding each patient’s unique needs and goals
  • Offering personalized surgical and medical treatment options
  • Coordinating multidisciplinary care for the best outcomes

Take the Next Step

If you or a loved one has been diagnosed with IDC or you have questions about breast health, our compassionate team is here to help. Contact Tucson Breast Health Specialists today to schedule a consultation and begin personalized care.

Board-Certified Surgeon

MICHELE LEY, MD, FACS

Dr. Ley, a breast surgical oncologist in Tucson since 2006, delivers compassionate and personalized care to create tailored treatment plans based on the latest research. Specializing in surgical care for breast cancer and high-risk patients, she employs minimally invasive techniques and practices oncoplastic surgery to optimize outcomes.

More About Dr. Ley

“The level of care is excellent.”

Dr. Ley is an excellence breast oncology surgeon, with incredible knowledge and genuine compassion. From the initial consultation to post-operative care, Dr. Ley’s meticulous approach and comprehensive understanding of breast oncology instilled confidence and eased my anxieties. The dedication to her patient’s well-being extends far beyond medical procedures; she fosters a supportive environment where empathy and personalized care is a priority.What sets Dr. Ley apart is her ability to treat not just the disease but the individual, providing unwavering support and guidance throughout the journey. Her warmth, coupled with a skilled surgical hand, empower patients with hope and resilience. Dr. Ley’s practice, marked by professionalism and kindness from every member of her team, ensures that patients receive not only top-notch medical care but also a nurturing environment conducive to healing. Dr. Ley is a beacon of hope and excellence in battling breast cancer.

I have no words to express my gratitude for Dr. Ley! I was diagnosed Feb. 2020 and Dr. Ley besides being the best in her field and doing an amazing job on my double mastectomy she was even able to save my nipples. She is also a remarkable human being, patient, kind very clear in explaining everything and making you feel heard and safe in her hands. I 100% recommend her and her very helpful, kind and amazing team! If you have recently been diagnosed this is the team you want to have your back!

Dr. Ley is extremely good at explaining your breast cancer, treatment options, and everything she is going to do. She is a masterful surgeon and uses plastic techniques to close incisions, leaving minimal scarring. In addition, she is warm, pleasant, and a lovely person. I am so happy that I found her based on a friend’s recommendation. I can’t say enough about her and the practice’s excellent care.

ABOUT US

More About Us

OUR BLOG

Read Our Blog

CONTACT US

We are dedicated to providing the support you need. Contact us today to learn more about how we can help on your breast health journey.

We are only accepting patients with surgical breast diseases. We do not see patients for breast pain or without imaging in the last three months. If you have been diagnosed with one of the following, please submit the contact form or call our office at (520) 605-2778 to schedule your appointment.

  • Breast cancer, DCIS (ductal carcinoma in situ), LCIS (lobular carcinoma in situ), invasive ductal carcinoma, invasive lobular carcinoma, and any other breast malignancies such as sarcoma, and malignant phyllodes
  • Patients with known genetic mutations such as BRCA 1, 2, and others
  • Fibroadenoma, phyllodes tumor, radial scar, complex sclerosing lesion, papilloma >8mm, atypical papilloma, nipple mass or ulceration,
  • Granulomatous mastitis
  • Atypical ductal or lobular hyperplasia ( ALH, ADH), and any benign lesion with atypia